XML 63 R46.htm IDEA: XBRL DOCUMENT
v3.25.1

Collaborative Agreements (Details) - Collaborative Arrangement - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended
--- | --- | ---
Apr. 30, 2018 | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2019 | Dec. 31, 2018
ApolloBio Corporation |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Upfront payment received |  | $ 0 | $ 3,600 |  |
ApolloBio |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Additional revenue to be achieved |  | $ 20,000 |  |  |
Obligation period to pay royalties |  | 10 years |  |  |
Funding received |  | $ 218 | 245 |  |
Coalition for Epidemic Preparedness Innovations |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Upfront payment received |  | 1,600 | 1,800 |  |
Coalition for Epidemic Preparedness Innovations | Lassa Fever And MERS Vaccine |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Collaborative agreement, funding to be received |  | 56,000 |  |  |
Collaborative agreement, period to receive funding for research and development | 5 years |  |  |  |
Bill And Melinda Gates Foundation | D N A Encoded Monoclonal Antibody Technology |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Collaborative agreement, funding to be received |  | $ 39 | $ 70 | $ 1,100 | $ 2,200

X
- Definition Collaboration Agreement, Additional Revenue To Be Achieved + References No definition available. + Details
Name: | ino_CollaborationAgreementAdditionalRevenueToBeAchieved
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaboration Agreement, Royalty Period + References No definition available. + Details
Name: | ino_CollaborationAgreementRoyaltyPeriod
Namespace Prefix: | ino_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaborative Agreement, Funding Received + References No definition available. + Details
Name: | ino_CollaborativeAgreementFundingReceived
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Collaborative Agreement, Funding Received for Research and Development + References No definition available. + Details
Name: | ino_CollaborativeAgreementFundingToBeReceived
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Collaborative Agreement, Period to Receive Funding for Research and Development + References No definition available. + Details
Name: | ino_CollaborativeAgreementPeriodtoReceiveFundingforResearchandDevelopment
Namespace Prefix: | ino_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaborative Agreements, Upfront Payment Received + References No definition available. + Details
Name: | ino_CollaborativeAgreementsUpfrontPaymentReceived
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=ino_AdvaccineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ino_ApolloBioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ino_CoalitionforEpidemicPreparednessInnovationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ino_LassaFeverAndMERSVaccineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ino_BillAndMelindaGatesFoundationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ino_DNAEncodedMonoclonalAntibodyTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |